Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute complete spinal cord injury patients
Phase 1
- Conditions
- acute complete spinal cord injury
- Registration Number
- JPRN-UMIN000013955
- Lead Sponsor
- Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Allergy for G-CSF 2. Hematologic malignancy 3. Past history of any kind of malignancy within 5 years 4. Severe co-morbidity 5. Thorombosis 6. Splenomegaly 7. Consciousness disorder 8. Pregnancy 9. Neurological disorder which can affect neurological evaluation in the present trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method